Biodegradable submicroscopic particles containing a biologically active substance and compositions containing them

Claim 2

Biodegradable particles having a diameter less than 500 nanometers for oral or parenteral administration in a human or animal host, said particles comprising a substantially spherical, dense, filamentous, polymeric network, wherein the polymeric network has dispersed therethrough a biologically active substance, and wherein said polymer is biodegradable in said host and is formed by the micellar polymerization of an alkyl cyano-acrylate said alkyl group containing 1 to 4 carbon atoms, and when said polymer particles are biodegraded in said host, the biologically active substance is progressively released into said host at a rate substantially corresponding to the rate of biodegradation of said polymer.

Claim 3

Biodegradable particles according to claim 1, which have a diameter of less than 200 nanometers.

Claim 4

Biodegradable particles according to claim 1 or 2 in which the biologically active substance is a product with antimitotic, antineoplastic, antibiotic or hormonal properties, a virus, a virus component, a bacterium component, a cell component, an antigen, an allergen or an enzyme.

Claim 5

A pharmaceutical composition containing biodegradable particles as defined according to claim 3 and an excipient for orally, subcutaneously, intradermally, intramuscularly or intraveneously administering said composition.

Claim 6

Biodegradable particles according to claim 1 or 2 formed by the polymerization of methyl-cyano-acrylate.

Claim 7

A pharmaceutical composition containing biodegradable particles as defined according to claim 5 and an excipient for orally, subcutaneously, intradermally, intramusuclarly or intraveneously administering said composition.

Claim 8

Biodegradable particles according to claim 5 in which the biologically active substance is a product with antimitotic, antineoplastic, antibiotic or hormonal properties, a virus, a virus component, a bacterium component, a cell component, an antigen, an allergen or an enzyme.

Claim 9

A pharmaceutical composition containing biodegradable particles as defined according to claims 1, 2 or 5 and an excipient for orally, subcutaneously, intradermally, intramuscularly or intraveneously administering said composition.

Claim 10

Biodegradable particles having a diameter less than 500 nanometers for parenteral administration in a human or animal host, said particles comprising a substantially spherical, dense, filamentous, polymeric network wherein the polymeric network has dispersed therethrough a biologically active substance, and wherein said polymer is biodegradable in said host and is formed by the micellar polymerization of an alkyl cyano-acrylate in an aqueous solution of a non-ionic surface active agent and at a pH less than 7, said alkyl containing 1 to 4 carbon atoms, and when said polymer particles are biodegraded in said host, the biologically active substance is progressively released into said host at a rate substantially corresponding to the rate of biodegradation of said polymer.

Claim 11

Biodegradable particles having a diameter less than 500 nanometers for parenteral administration in a human or animal host, said particles comprising a substantially spherical, dense, filamentous, polymeric network wherein the polymeric network has dispersed therethrough a biologically active substance, and wherein said polymer is biodegradable in said host and is formed by the micellar polymerization of an alkyl cyano-acrylate in an aqueous solution of a non-ionic surface active agent and at a pH less than 7, said alkyl containing 1 to 4 carbon atoms, and when said polymer particles are biodegraded in said host, the biologically active substance is progressively released into said host at a rate substantially corresponding to the rate of biodegradation of said polymer.

Claim 12

Biodegradable particles according to claim 9 in the form of a mixture of nanoparticles formed from different alkyl cyano-acrylates to thereby provide nanoparticles in said mixture having different degradability kinetics in the host.

Claim 13

Biodegradable particles having a diameter less than 500 nanometers for use as a diagnostic agent, said particles comprising a substantially spherical, dense, filamentous, polymeric network wherein the polymeric network has dispersed therethrough a biologically active substance, and wherein said polymer is biodegradable and is formed by the micellar polymerization of an alkyl cyano-acrylate in an aqueous solution of a surface active agent and at a pH less than 7, said alkyl containing 1 to 4 carbon atoms, and wherein said polymer particles are biodegraded in use as a diagnostic agent whereby the biologically active substance is progressively released at a rate substantially corresponding to the rate of biodegradation of said polymer.

Claim 14

Biodegradable particles having a diameter less than 500 nanometers for use as a diagnostic agent, said particles comprising a substantially spherical, dense, filamentous, polymeric network wherein the polymeric network has dispersed therethrough a biologically active substance, and wherein said polymer is biodegradable and is formed by the micellar polymerization of an alkyl cyano-acrylate in an aqueous solution of a surface active agent and at a pH less than 7, said alkyl containing 1 to 4 carbon atoms, and wherein said polymer particles are biodegraded in use as a diagnostic agent whereby the biologically active substance is progressively released at a rate substantially corresponding to the rate of biodegradation of said polymer.

Claim 15

Biodegradable particles according to claim 11 in the form of a mixture of nanoparticles formed from different alkyl cyano-acrylates to thereby provide nanoparticles in said mixture having different degradability kinetics.